Loading chat...
NY A03496
Bill
Status
Introduced
1/28/2025
Primary Sponsor
John McDonald
Click for details
AI Summary
- Authorizes licensed pharmacists to prescribe, administer, and dispense FDA-approved medication-assisted treatment (including buprenorphine) for opioid use disorder under Schedule III, IV, and V controlled substances
- Requires pharmacists to register with the federal Drug Enforcement Administration and complete training required by Section 303 of the Controlled Substances Act before prescribing these medications
- Mandates the Commissioner of Health establish a statewide protocol for pharmacist prescribing of medication-assisted treatment within 90 days of the law's effective date
- Requires pharmacists to provide patients with information about the importance of having a primary health care practitioner and to report any treatment administered to the patient's existing providers
- Allows licensed physicians to prescribe non-patient-specific regimens to pharmacists for treating patients with opioid use disorder; takes effect 180 days after becoming law
Legislative Description
Allows a licensed pharmacist to prescribe and order FDA-approved medication assisted therapy under a non-patient-specific regimen for the treatment of opioid use disease.
Last Action
referred to higher education
1/7/2026
Committee Referrals
Higher Education1/28/2025
Full Bill Text
No bill text available